Stephen P. Carey Ani Pharmaceuticals Inc (ANIP) insider trading activity

Stephen P. Carey is SVP & CFO of ANI PHARMACEUTICALS INC. Currently has a direct ownership of 161,968 shares of ANIP, which is worth approximately $9.22 Million. The most recent transaction as insider was on Jun 04, 2024, when has been sold 5,000 shares (Common Stock) at a price of $63.58 per share, resulting in proceeds of $317,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 162K

0% 3M change

3.93% 12M change

Total Value Held $9.22 Million

STEPHEN P. CAREY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 04 2024	SELL Open market or private sale	$317,900 $63.58 p/Share	5,000 Reduced 2.99%	161,968 Common Stock
Apr 10 2024	SELL Payment of exercise price or tax liability	$303,596 $66.96 p/Share	4,534 Reduced 2.64%	166,968 Common Stock
Mar 23 2024	SELL Payment of exercise price or tax liability	$432,091 $69.58 p/Share	6,210 Reduced 3.49%	171,502 Common Stock
Mar 11 2024	SELL Open market or private sale	$510,437 $65.55 p/Share	7,787 Reduced 4.2%	177,712 Common Stock
Mar 07 2024	SELL Payment of exercise price or tax liability	$281,249 $66.71 p/Share	4,216 Reduced 2.22%	185,499 Common Stock
Feb 29 2024	SELL Payment of exercise price or tax liability	$129,520 $67.67 p/Share	1,914 Reduced 1.0%	189,715 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	35,790 Added 15.74%	191,629 Common Stock
Aug 14 2023	SELL Open market or private sale	$1,082,505 $61.37 p/Share	17,639 Reduced 10.17%	155,839 Common Stock
Apr 10 2023	SELL Payment of exercise price or tax liability	$174,559 $38.5 p/Share	4,534 Reduced 2.55%	173,478 Common Stock
Mar 28 2023	SELL Payment of exercise price or tax liability	$54,840 $38.62 p/Share	1,420 Reduced 1.02%	137,486 Common Stock
Mar 23 2023	SELL Payment of exercise price or tax liability	$159,751 $37.82 p/Share	4,224 Reduced 2.95%	138,906 Common Stock
Mar 07 2023	SELL Payment of exercise price or tax liability	$154,937 $44.23 p/Share	3,503 Reduced 2.39%	143,130 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	-	40,526 Added 18.54%	178,012 Common Stock
Apr 27 2022	BUY Grant, award, or other acquisition	-	11,291 Added 7.15%	146,633 Common Stock
Apr 10 2022	SELL Payment of exercise price or tax liability	$135,612 $29.91 p/Share	4,534 Reduced 3.24%	135,342 Common Stock
Apr 06 2022	SELL Payment of exercise price or tax liability	$27,077 $29.69 p/Share	912 Reduced 0.65%	139,876 Common Stock
Mar 28 2022	SELL Payment of exercise price or tax liability	$40,001 $28.17 p/Share	1,420 Reduced 1.0%	140,788 Common Stock
Mar 24 2022	BUY Grant, award, or other acquisition	-	33,875 Added 19.24%	142,208 Common Stock
Mar 23 2022	SELL Payment of exercise price or tax liability	$112,634 $27.03 p/Share	4,167 Reduced 3.7%	108,333 Common Stock
Apr 12 2021	SELL Payment of exercise price or tax liability	$96,918 $31.86 p/Share	3,042 Reduced 2.63%	112,500 Common Stock
Apr 06 2021	SELL Payment of exercise price or tax liability	$20,618 $33.69 p/Share	612 Reduced 0.53%	115,542 Common Stock
Mar 31 2021	SELL Payment of exercise price or tax liability	$18,359 $36.14 p/Share	508 Reduced 0.44%	116,154 Common Stock
Mar 29 2021	SELL Payment of exercise price or tax liability	$31,144 $32.68 p/Share	953 Reduced 0.81%	116,662 Common Stock
Mar 23 2021	BUY Grant, award, or other acquisition	-	54,470 Added 31.65%	117,615 Common Stock

SPC

Stephen P. Carey

SVP & CFO

Baudette, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANIP shares.

Notify only if

Value

Insider Trading

Get notified when an Ani Pharmaceuticals Inc insider buys or sells ANIP shares.

Notify only if

Operation

Value

Type

News

Receive news related to ANI PHARMACEUTICALS INC

Track Activities on ANIP

Account